Edwards Lifesciences Acquires JenaValve and Endotronix to Expand Structural Heart and Heart Failure Portfolio

Johnson & Johnson Completes Acquisition of V‑Wave Ltd.

October 9, 2024

Medical Devices

Johnson & Johnson has completed its acquisition of V‑Wave Ltd., adding V‑Wave’s Ventura Interatrial Shunt to the Johnson & Johnson MedTech portfolio. The transaction was accounted for as an asset acquisition and will result in an in‑process R&D charge of approximately $600 million as J&J expands its cardiovascular and heart‑failure capabilities.

Boston Scientific Acquires Valencia Technologies

January 12, 2026

Medical Devices

On January 12, 2026, Boston Scientific acquired Valencia Technologies, the developer of the eCoin System — a coin-sized subcutaneous neuromodulation device for hypertension. The acquisition expands Boston Scientific's neuromodulation and cardiovascular device portfolio by adding a novel, minimally invasive therapy and provides Valencia access to Boston Scientific's regulatory, distribution, and commercialization resources.

IDEX Corporation Acquires Airtech Group and US Valve from EagleTree Capital

April 27, 2021

Manufacturing

IDEX Corporation agreed to acquire Airtech Group, Inc., US Valve Corporation and related entities from investment funds managed by EagleTree Capital for $470 million in cash (subject to customary adjustments). The acquisition brings engineered vacuum pumps, regenerative blowers, compressor systems and valves into IDEX's Health & Science Technology segment; Airtech's largest facility is in Rutherford, New Jersey, with additional operations in Werneck, Germany and Shenzhen, China.

Johnson & Johnson Acquires Abiomed

December 22, 2022

Medical Devices

Johnson & Johnson completed its acquisition of Abiomed on December 22, 2022, acquiring all outstanding shares for $380.00 per share (approximately $16.6 billion enterprise value) plus a contingent value right. Abiomed will operate as a standalone business within Johnson & Johnson's MedTech segment, expanding J&J's capabilities in high-growth cardiovascular and heart-recovery solutions.

Integra LifeSciences Acquires Acclarent, Inc.

April 1, 2024

Medical Devices

Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.

Stryker Acquires Cerus Endovascular

May 2, 2023

Medical Devices

Stryker has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company that developed the Contour Neurovascular System and Neqstent devices for treatment of intracranial aneurysms. The deal expands Stryker’s Neurovascular portfolio and strengthens its aneurysm/hemorrhagic treatment capabilities globally (reported purchase price approximately $530 million).